{
  "id": 547,
  "text": "Lymphedema was significantly associated with radical hysterectomy with pelvic lymphadenectomy.# 10.1.2 Primary chemoradiotherapy Kong et al.536 compared treatment outcomes and treatment–related morbidities of radical hysterectomy followed by adjuvant therapy (radiotherapy or chemoradiotherapy) and primary chemoradiotherapy in patients with FIGO stages IB-IIA cervical cancer.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Lymphedema was significantly associated with radical hysterectomy with pelvic lymphadenectomy.# 10.1.2 Primary chemoradiotherapy Kong et al.536 compared treatment outcomes and treatment–related morbidities of radical hysterectomy followed by adjuvant therapy (radiotherapy or chemoradiotherapy) and primary chemoradiotherapy in patients with FIGO stages IB-IIA cervical cancer.\n\n<question>: ",
  "ChatGPT_response_0": "在FIGO分期IB-IIA的子宫颈癌患者中，选择接受根治性子宫切除术后辅助治疗（放疗或化疗放疗）还是选择原发性化疗放疗治疗取决于多种因素。一般来说，根据患者的具体情况和医生的建议来做出决定是最为重要的。\n\n根治性子宫切除术后的辅助治疗可以有效清除残留的病灶并减少复发概率，特别是对于已经形成的癌旁组织。然而，手术可能会带来一些并发症，例如淋巴水肿等，需要患者注意。\n\n另一方面，原发性化疗放疗也是治疗子宫颈癌的一种有效方法，尤其对于那些手术不适宜或不愿意接受手术的患者来说。通过化疗和放疗的综合治疗，也可以达到一定的疗效。\n\n因此，在做决定时，应该综合考虑患者的具体情况、疾病发展程度、手术风险、治疗效果等因素，并根据医生的建议选择最合适的治疗方案。最终的治疗方案应该是一个综合决策，为患者提供最佳的治疗效果和生活质量。",
  "query": "子宫颈癌患者在FIGO分期IB-IIA情况下，您认为是选择接受根治性子宫切除术后辅助治疗（放疗或化疗放疗）还是选择原发性化疗放疗来治疗，您有什么看法？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 子宫颈癌患者在FIGO分期IB-IIA情况下，您认为是选择接受根治性子宫切除术后辅助治疗（放疗或化疗放疗）还是选择原发性化疗放疗来治疗，您有什么看法？\n\n<reference text>: Lymphedema was significantly associated with radical hysterectomy with pelvic lymphadenectomy.# 10.1.2 Primary chemoradiotherapy Kong et al.536 compared treatment outcomes and treatment–related morbidities of radical hysterectomy followed by adjuvant therapy (radiotherapy or chemoradiotherapy) and primary chemoradiotherapy in patients with FIGO stages IB-IIA cervical cancer.\n\n<reply>: ",
  "response": "在FIGO分期IB-IIA的子宫颈癌患者中，选择接受根治性子宫切除术后辅助治疗（放疗或化疗放疗）还是选择原发性化疗放疗治疗取决于多种因素。一般来说，根据患者的具体情况和医生的建议来做出决定是最为重要的。\n\n根治性子宫切除术后的辅助治疗可以有效清除残留的病灶并减少复发概率，特别是对于已经形成的癌旁组织。然而，手术可能会带来一些并发症，例如淋巴水肿等，需要患者注意。\n\n另一方面，原发性化疗放疗也是治疗子宫颈癌的一种有效方法，尤其对于那些手术不适宜或不愿意接受手术的患者来说。通过化疗和放疗的综合治疗，也可以达到一定的疗效。\n\n因此，在做决定时，应该综合考虑患者的具体情况、疾病发展程度、手术风险、治疗效果等因素，并根据医生的建议选择最合适的治疗方案。最终的治疗方案应该是一个综合决策，为患者提供最佳的治疗效果和生活质量。"
}